When Patients With Depression Have Cognitive Deficits

Slides:



Advertisements
Similar presentations
Treating Depression in the Primary Care Setting Pharmacologic Interventions Presented by: Jonathan Betlinski, MD Date: 09/25/2014.
Advertisements

Psychopharmacology – A brief introduction. Objectives Review general categories of psychiatric disorders Review general categories of psychiatric disorders.
Basics of outpatient depression management Chris Zamani MD.
Psychotherapies in Treatment of Depression Copyright © World Psychiatric Association.
Chapter Depression Barbour, Hoffman, and Blumenthal C H A P T E R.
Depression and Aging Aging Q 3 William P. Moran, MD, MS Medical University of South Carolina October 31, 2012.
Upfront Combination Therapy vs Step-Up Approach for PAH:
Major Depressive Disorder: Latest Clinical Update
Key Issues in Depression: Highlights From APA 2016
COPD by the Guidelines.
How the Latest Data in MDD Can Guide Treatment Decisions:
Psoriatic Arthritis.
Program Overview. Primary Care Approaches to Cognitive Dysfunction in Major Depressive Disorder.
Primary Care Challenges in Depression - To Treat or Refer?
Major Depressive Disorder: Getting the Patient Back to Work
Monitoring and Management of Adult Relapsed/Refractory Acute Promyelocytic Leukemia.
Focus on MDD: Real World Perspectives for Improving Care
Advances in Managing Inhibitors in Patients With Hemophilia A
What Is Major Depressive Disorder (MDD)?
Does One Size Fit All in Obesity Management?
Progression After Cancer Immunotherapy in Advanced NSCLC
Introduction. Clinical Pearls on the Management of Immune-Mediated Adverse Events Affecting the Endocrine System.
The Patient Journey to Remission in MDD: A Collaborative Approach
Understanding Biologics
From the 2015 Conferences to the Clinic
From Conference to the Clinic
New Challenges Facing Multiple Sclerosis Nurses
COPD Management.
The Comprehensive Major Depressive Disorder Care Team
Clinical Presentations of VTEa,b NOACs VTE Acute Treatment Trials.
Early Dementia Distinguishing AD From MCI
The Mood Disorder Spectrum
What Would You Do in This Case of MDD?
A Call to Action on Cryptogenic Stroke
IL-17 Inhibitors in the Management of Psoriatic Disease
Screening and Diagnosing Postpartum Depression
Addressing Disease Burden in Asthma
Decision-making in the eRA of Treating to Target
Are We Closer to Personalized Medicine in MS?
New Pathways in Lipid Care
Managing IBD.
Managing Depression is a Team Effort:
Hyperhidrosis Is Burdensome!
Emerging Atopic Dermatitis Treatments:
Tackling Atopic Dermatitis
Expert Debate in MDD.
Ask the Experts.
Clinical Recognition and Treatment of Levodopa-Induced Dyskinesia
Translating the Latest and Greatest Advances in PAH Into Clinical Practice.
When Is Biologic Therapy Appropriate for HS?
What Is Bipolar Disorder?
Program Overview. Major Depressive Disorder: The Challenging Patient and the Goal of Recovery.
Current and Emerging Strategies for Management of Moderate-to-Severe Atopic Dermatitis.
Battling the Flu: Latest Advances in the Influenza Treatment Arsenal
Scientific Update.
Guide to Atopic Dermatitis
Management of Systemic Lupus Erythematosus
Atopic Dermatitis in the Pediatric Practice
Optimizing Joint Health in Hemophilia
Add-On Therapy to Insulin in T1DM Management
Communicating With Your Patients About Major Depressive Disorder
Updates in RA, PsA, and Biosimilars
Improving Overall Health
What You Need To Know To Effectively Manage Patients With MDD Key Terms (cont)
Disease Burden of VTE Phases of VTE Treatment.
Binge Eating Disorder.
The Building Blocks of Homocystinuria and Homocysteinemia Management
Changing Paradigms in Relapsed/Refractory Indolent NHL
Key Data on Improving Outcomes in HF Patients
Shared Decision Making in MS
Presentation transcript:

When Patients With Depression Have Cognitive Deficits

Criteria for a Major Depressive Episode

Key Domains The Elements of Cognition

Why Is Cognitive Impairment Important?

Cognitive Measures Account for More Variability in Workplace Functioning Than Total Depression Severity

Cognitive Domains

Assessing and Monitoring Cognition

Assessment by Interview

Tests for Clinical Use

The THINC-it Cognition Tool Includes Several Tests, Objective and Subjective

Treatment for Acute Depression

Effect of Diet and Exercise on Cognition in Depression

Cognitive Remediation

Cognitive Dysfunction in MDD Seems to Improve Following Psychotherapy

Hot and Cold Cognition in Depression

Pharmacologic Effects on Cognitive Function in Young Adults With MDD Limited Evidence With Most Psychotropic Agents

Adjunctive Cholinesterase Inhibitors Not Effective for Cognition in MDD

Antidepressant Effects on Cognitive Domains

Escitalopram vs Duloxetine for Cognition in MDD

Duloxetine Effect on Cognition in Elderly Patients With Recurrent MDD

Vortioxetine and Duloxetine Effect on Cognition in Elderly Patients With MDD

Effect of Vortioxetine on Cognition in MDD

Vortioxetine and Duloxetine for Cognition and Function in MDD

Lisdexamfetamine Augmentation for Executive Function in Mild MDD

Concluding Remarks

Abbreviations

Abbreviations (cont)